Volcano (FRA:VQY) Days Inventory : 177.14 (As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Volcano Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Volcano's Average Total Inventories for the three months ended in Sep. 2014 was €56.2 Mil. Volcano's Cost of Goods Sold for the three months ended in Sep. 2014 was €28.9 Mil. Hence, Volcano's Days Inventory for the three months ended in Sep. 2014 was 177.14.

The historical rank and industry rank for Volcano's Days Inventory or its related term are showing as below:

FRA:VQY's Days Inventory is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 192.78
* Ranked among companies with meaningful Days Inventory only.

Volcano's Days Inventory increased from Sep. 2013 (171.15) to Sep. 2014 (177.14). It might indicate that Volcano's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Volcano's Inventory Turnover for the three months ended in Sep. 2014 was 0.52.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Volcano's Inventory-to-Revenue for the three months ended in Sep. 2014 was 0.74.

Volcano Days Inventory Historical Data

The historical data trend for Volcano's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Volcano Days Inventory Chart

Volcano Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Days Inventory

Get a 7-Day Free Trial

137.49

125.26

130.01

133.09

147.85

Volcano Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Days Inventory	Get a 7-Day Free Trial															171.15	145.35	168.19	167.85	177.14

Competitive Comparison of Volcano's Days Inventory

For the Medical Devices subindustry, Volcano's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Volcano's Days Inventory Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Volcano's Days Inventory distribution charts can be found below:

* The bar in red indicates where Volcano's Days Inventory falls into.

Volcano Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Volcano's Days Inventory for the fiscal year that ended in Dec. 2013 is calculated as

	Days Inventory (A: Dec. 2013 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2012 )	+	Total Inventories (A: Dec. 2013 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2013 )	*	Days in Period
=	( (40.242	+	44.508)	/	2 )	/	104.611	*	365
=	42.375					/	104.611	*	365
=	147.85

Volcano's Days Inventory for the quarter that ended in Sep. 2014 is calculated as:

	Days Inventory (Q: Sep. 2014 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2014 )	+	Total Inventories (Q: Sep. 2014 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2014 )	*	Days in Period
=	( (53.117	+	59.241)	/	2 )	/	28.939	*	365 / 4
=	56.179					/	28.939	*	365 / 4
=	177.14

Volcano (FRA:VQY) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Volcano's Inventory Turnover for the three months ended in Sep. 2014 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	28.939	/	56.179
	=	0.52

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Volcano's Inventory to Revenue for the three months ended in Sep. 2014 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	56.179	/	75.627
	=	0.74

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Volcano Days Inventory Related Terms

Thank you for viewing the detailed overview of Volcano's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Volcano (FRA:VQY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Volcano Corp (FRA:VQY) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.volcanocorp.com

Volcano Corp incorporated in the state of Delaware in January 2000. The Company completed its initial public offering on June 15, 2006. The Company designs, develops, manufactures and commercializes a broad suite of precision guided therapy tools including intravascular ultrasound, or IVUS, and fractional flow reserve, or FFR, products. The IVUS products include single-procedure disposable phased array and rotational IVUS imaging catheters, and additional functionality options such as ChromaFlo stent apposition analysis. FFR offerings can be accessed through its multi-modality platforms, and it also provide FFR-only consoles. Its products include: IVUS Products, Catheters, its single-use disposable catheters operate and interface solely with its family of consoles. Catheters, its single-use disposable catheters operate and interface solely with its family of consoles. ChromaFlo stent apposition analysis technology uses sequential IVUS frames to differentiate circulating blood from stationary or anchored tissue. SyncVision, Sync-Rx Ltd, or Sync-Rx, an Israel-based company that develops advanced software applications designed to optimize and facilitate trans-catheter cardiovascular interventions using automated online image processing. FFR products consist of pressure and flow consoles and single-procedure disposable pressure and flow guide wires. The Company's primary imaging competitors globally are Boston Scientific, Inc., or Boston Scientific, with its IVUS offering and St. Jude Medical, Inc., or St. Jude with its OCT offering. In Japan, it also competes with Terumo Corporation, which offers both IVUS and OCT. In the FFR market, its primary competitor is St. Jude. Because of the size of the vascular market opportunities, competitors and potential competitors have dedicated and will continue to dedicate significant resources to aggressively promote their products. It has registered and common law trademarks in the U.S. and elsewhere in the world including, but not limited to, Aim, Axsun, Bi-Trieval, Centriq, ChromaFlo, ComboMap, ComboWire, Core, Crux, Crux Biomedical, Define, Eagle Eye, ETNA, FACT, FloMap, FloWire, Ginko, GlyDx, Hi-Q, iFR, In-Line Digital, Instant Wave-Free Ratio, Intentio, Octave, pcFM, Precision Guided Therapy, PreView, PrimeWire, PrimeWire Prestige, ReFlow, Revolution, SlyDx, s5i, SmartMap, SpinVision, Sync-Rx, Trak Back, Valet, Verrata, VH, VIBE, Virtual Histology, Visions, Volcano, Wavewire, Xtract and Zuum. The Company's medical device products are subject to extensive and rigorous regulation by the FDA, as well as other federal and state regulatory bodies in the U.S. and comparable authorities in other countries.

Volcano (FRA:VQY) Headlines

No Headlines